Modulation of β-catenin function maintains mouse epiblast stem cell and human embryonic stem cell self-renewal

Tesar, P. J. et al. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448, 196–199 (2007). 10.1038/nature05972

[3]

Watanabe, K. et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat. Biotechnol. 25, 681–686 (2007). 10.1038/nbt1310

[4]

van Amerongen, R. & Nusse, R. Towards an integrated view of Wnt signalling in development. Development 136, 3205–3214 (2009). 10.1242/dev.033910

[5]

THE WNT SIGNALING PATHWAY IN DEVELOPMENT AND DISEASE

Catriona Y. Logan, Roel NUSSE

Annual Review of Cell and Developmental Biology 2004 10.1146/annurev.cellbio.20.010403.113126

[6]

Clevers, H. Wnt/β-catenin signalling in development and disease. Cell 127, 469–480 (2006). 10.1016/j.cell.2006.10.018

[7]

Nusse, R. Wnt signalling and stem cell control. Cell Res. 18, 523–527 (2008). 10.1038/cr.2008.47

[8]

ten Berge, D. et al. Embryonic stem cells require Wnt proteins to prevent differentiation to epiblast stem cells. Nat. Cell Biol. 13, 1070–1075 (2011). 10.1038/ncb2314

[9]

Ying, Q. L. et al. The ground state of embryonic stem cell self-renewal. Nature 453, 519–523 (2008). 10.1038/nature06968

[10]

Hasegawa, K. et al. Wnt signalling orchestration with a small molecule DYRK inhibitor provides long-term xeno-free human pluripotent cell expansion. Stem Cells Transl. Med. 1, 18–28 (2012). 10.5966/sctm.2011-0033

[11]

Sokol, S. Y. Maintaining embryonic stem cell pluripotency with Wnt signalling. Development 138, 4341–4350 (2011). 10.1242/dev.066209

[12]

Wray, J. et al. Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation. Nat. Cell Biol. 13, 838–845 (2011). 10.1038/ncb2267

[13]

Huang, S. M. et al. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461, 614–620 (2009). 10.1038/nature08356

[14]

Yeom, Y. I. et al. Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. Development 122, 881–894 (1996). 10.1242/dev.122.3.881

[15]

Bao, S. et al. Epigenetic reversion of post-implantation epiblast to pluripotent embryonic stem cells. Nature 461, 1292–1295 (2009). 10.1038/nature08534

[16]

Maldonado-Saldivia, J. et al. Dppa2 and Dppa4 are closely linked SAP motif genes restricted to pluripotent cells and the germ line. Stem Cells 25, 19–28 (2007). 10.1634/stemcells.2006-0269

[17]

Han, D. W. et al. Epiblast stem cell subpopulations represent mouse embryos of distinct pregastrulation stages. Cell 143, 617–627 (2010). 10.1016/j.cell.2010.10.015

[18]

Chen, B. et al. Small molecule-mediated disruption of Wnt-dependent signalling in tissue regeneration and cancer. Nat. Chem. Biol. 5, 100–107 (2009). 10.1038/nchembio.137

[19]

Thorne, C. A. et al. Small-molecule inhibition of Wnt signalling through activation of casein kinase 1α. Nat. Chem. Biol. 6, 829–836 (2010). 10.1038/nchembio.453

[20]

Wnt/β-Catenin/Tcf Signaling Induces the Transcription of Axin2, a Negative Regulator of the Signaling Pathway

Eek-hoon Jho, Tong Zhang, Claire Domon et al.

Molecular and Cellular Biology 2002 10.1128/mcb.22.4.1172-1183.2002

[21]

Lo Celso, C., Prowse, D. M. & Watt, F. M. Transient activation of beta-catenin signalling in adult mouse epidermis is sufficient to induce new hair follicles but continuous activation is required to maintain hair follicle tumours. Development 131, 1787–1799 (2004). 10.1242/dev.01052

[22]

Graham, T. A., Weaver, C., Mao, F., Kimelman, D. & Xu, W. Crystal structure of a β-catenin/Tcf complex. Cell 103, 885–896 (2000). 10.1016/s0092-8674(00)00192-6

[23]

Faunes, F. et al. A membrane-associated beta-catenin/Oct4 complex correlates with ground-state pluripotency in mouse embryonic stem cells. Development 140, 1171–1183 (2013). 10.1242/dev.085654

[24]

Orsulic, S., Huber, O., Aberle, H., Arnold, S. & Kemler, R. E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. J. Cell Sci. 112, (Pt 8): 1237–1245 (1999). 10.1242/jcs.112.8.1237

[25]

Hanna, J. et al. Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc. Natl Acad. Sci. USA 107, 9222–9227 (2010). 10.1073/pnas.1004584107

[26]

Rossant, J. Stem cells and early lineage development. Cell 132, 527–531 (2008). 10.1016/j.cell.2008.01.039

[27]

Yamada, S., Pokutta, S., Drees, F., Weis, W. I. & Nelson, W. J. Deconstructing the cadherin-catenin-actin complex. Cell 123, 889–901 (2005). 10.1016/j.cell.2005.09.020

[28]

Sato, N., Meijer, L., Skaltsounis, L., Greengard, P. & Brivanlou, A. H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signalling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 10, 55–63 (2004). 10.1038/nm979

[29]

Cai, L. et al. Promoting human embryonic stem cell renewal or differentiation by modulating Wnt signal and culture conditions. Cell Res. 17, 62–72 (2007). 10.1038/sj.cr.7310138

[30]

Dravid, G. et al. Defining the role of Wnt/β-catenin signalling in the survival, proliferation, and self-renewal of human embryonic stem cells. Stem Cells 23, 1489–1501 (2005). 10.1634/stemcells.2005-0034

[31]

Davidson, K. C. et al. Wnt/beta-catenin signalling promotes differentiation, not self-renewal, of human embryonic stem cells and is repressed by Oct4. Proc. Natl Acad. Sci. USA. 109, 4485–4490 (2012). 10.1073/pnas.1118777109

[32]

Ogawa, K., Nishinakamura, R., Iwamatsu, Y., Shimosato, D. & Niwa, H. Synergistic action of Wnt and LIF in maintaining pluripotency of mouse ES cells. Biochem. Biophys. Res. Commun. 343, 159–166 (2006). 10.1016/j.bbrc.2006.02.127

[33]

Wray, J., Kalkan, T. & Smith, A. G. The ground state of pluripotency. Biochem. Soc. Trans. 38, 1027–1032 (2010). 10.1042/bst0381027

[34]

Tong, C., Huang, G., Ashton, C., Li, P. & Ying, Q. L. Generating gene knockout rats by homologous recombination in embryonic stem cells. Nat. Protoc. 6, 827–844 (2011). 10.1038/nprot.2011.338

[35]

Chenoweth, J. G. & Tesar, P. J. Isolation and maintenance of mouse epiblast stem cells. Methods Mol. Biol. 636, 25–44 (2010). 10.1007/978-1-60761-691-7_2

[36]

Hasegawa, K., Fujioka, T., Nakamura, Y., Nakatsuji, N. & Suemori, H. A method for the selection of human embryonic stem cell sublines with high replating efficiency after single-cell dissociation. Stem Cells 24, 2649–2660 (2006). 10.1634/stemcells.2005-0657

[37]

Brault, V. et al. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development 128, 1253–1264 (2001). 10.1242/dev.128.8.1253

[38]

Hanna, J. et al. Metastable pluripotent states in NOD-mouse-derived ESCs. Cell Stem Cell 4, 513–524 (2009). 10.1016/j.stem.2009.04.015

[39]

Guo, G. et al. Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development 136, 1063–1069 (2009). 10.1242/dev.030957

[40]

Kolligs, F. T., Hu, G., Dang, C. V. & Fearon, E. R. Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. Mol. Cell Biol. 19, 5696–5706 (1999). 10.1128/mcb.19.8.5696

[41]

Heckman, K. L. & Pease, L. R. Gene splicing and mutagenesis by PCR-driven overlap extension. Nat. Protoc. 2, 924–932 (2007). 10.1038/nprot.2007.132

[42]

Chambers, I. et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643–655 (2003). 10.1016/s0092-8674(03)00392-1

[43]

Ying, Q. L. & Smith, A. G. Defined conditions for neural commitment and differentiation. Methods Enzymol. 365, 327–341 (2003). 10.1016/s0076-6879(03)65023-8

[44]

Ying, Q. L., Stavridis, M., Griffiths, D., Li, M. & Smith, A. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat. Biotechnol. 21, 183–186 (2003). 10.1038/nbt780

Metrics

166

Citations

44

References

Details

Published: Aug 29, 2013
Vol/Issue: 4(1)
License: View

Authors

Southern University of Science and Technology

From Fundacion INFANT (F.P.P.) and iTrials-Hospital Militar Central (G.P.M.), Buenos Aires; State University of New York, Upstate Medical University, Syracuse (S.J.T.), and Vaccine Research and Development, Pfizer, Pearl River (J.A., A.G., K.A.S., K.K., W.V.K., D.C., P.R.D., K.U.J., W.C.G.) — both in New York; Vaccine Research and Development, Pfizer, Hurley, United Kingdom (N.K., S.L., R.B.); Vaccine Research and Development (J.L.P., P.L.) and Worldwide Safety, Safety Surveillance and Risk Management (S.M.), Pfizer, Collegeville, PA; Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Bahia (E.D.M.), and Centro Paulista de Investigação Clinica, São Paulo (C.Z.) — both in Brazil; Global Product Development, Pfizer, Peapack, NJ (S.R.); Cincinnati Children’s Hospital, Cincinnati (R.W.F.); Johns Hopkins Bloomberg School of Public Health, Baltimore (L.L.H.); BioNTech, Mainz (ÖT., U.Ş.), and Medizentrum Essen Borbeck, Essen (A.S.) — both in Germany; Tiervlei Trial Centre, Karl Bremer Hospital, Cape...

Cite This Article

Hoon Kim, Jun Wu, Shoudong Ye, et al. (2013). Modulation of β-catenin function maintains mouse epiblast stem cell and human embryonic stem cell self-renewal. Nature Communications, 4(1). https://doi.org/10.1038/ncomms3403

Modulation of β-catenin function maintains mouse epiblast stem cell and human embryonic stem cell self-renewal

You May Also Like